DULOXETINE HYDROCHLORIDE | N212516 | SUN PHARMACEUTICAL INDUSTRIES LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Kathy Lynn Bramel Easterday FDA-2026-P-1831 · 3 docket documents Kathy Lynn Bramel Easterday filed this petition under sections 502, 505, 701, and related provisions of the Federal Food, Drug, and Cosmetic Act requesting that the FDA Commissioner require NDA holders and generic manufacturers of Cymbalta (duloxetine hydrochloride) to develop and make available sta | 505(q) | 2026-02-19 | Open | Kathy Lynn Bramel Easterday |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$7.22
per ea
Lowest NADAC/Unit
$7.16
per ea
Brand NDCs
3
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 47335061730DRIZALMA SPRINKLE DR 30 MG CAP | $7.22 | EA | Brand | — | 2026-04-01 |
| 47335061630DRIZALMA SPRINKLE DR 20 MG CAP | $7.17 | EA | Brand | — | 2026-04-01 |
| 47335061930DRIZALMA SPRINKLE DR 60 MG CAP | $7.16 | EA | Brand | — | 2026-04-01 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.